Company / Inventory
ELITE PHARMACEUTICALS INC /NV/ Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$16.2M
FY2025
5-year range
$5.0M / $16.2M
FY2021-FY2025
Trend
+25.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Inventory has increased for 5 consecutive years, from $4M in FY2020 to $16M in FY2025.
Based on SEC 10-K filings.
$16M in FY2025 with a 5-year CAGR of +31.4%.
Improved from $10M to $16M over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- +34.1%
- 5-Year CAGR
- +31.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- ELITE PHARMACEUTICALS INC /NV/'s inventory has grown for 5 consecutive years.
- 5-year CAGR of +31.4%, indicating consistent growth.
- In FY2025, inventory increased 25.6% year-over-year.
- Lowest inventory in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $16.2M | +25.6% |
| FY2024 | $12.9M | +35.4% |
| FY2023 | $9.6M | +41.7% |
| FY2022 | $6.7M | +34.5% |
| FY2021 | $5.0M | +21.0% |
| FY2020 | $4.1M | -8.3% |
| FY2019 | $4.5M | -7.8% |
| FY2018 | $4.9M | -23.7% |
| FY2017 | $6.4M | +94.8% |
| FY2016 | $3.3M | +8.6% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026